Authors
Latest:
Refining Alzheimer Treatment Through Biomarker-Based Patient Selection: Michael Woodward, MD, FRACP; Anthony Caggiano, MD, PhDThe head of dementia research at Austin Health and the chief medical officer at Cognition Therapeutics talked about recently presented phase 2 findings on CT1812, an investigational medicine for patients with mild to moderate Alzheimer disease, at CTAD 2024. [WATCH TIME: 5 minutes]
Latest:
Raising Global Awareness for Epilepsy on Purple Day: Sonal Bhatia, MD, FACNSThe director of the pediatric epilepsy monitoring unit at the Medical University of South Carolina provided commentary on the significance of Purple Day as a means to raise awareness about epilepsy. [WATCH TIME: 3 minutes]
Latest:
Understanding the Clinical Advantages of Cladribine and its Impacts on Oligoclonal Bands: Nicola De Stefano, MD, PhDThe professor of neurology in the department of medicine, surgery, and neuroscience at the University of Siena, gave perspective on an analysis of the MAGNIFY-MS study, in which treatment with cladribine demonstrated impacts on CNS-related pathology in MS. [WATCH TIME: 4 minutes]
Latest:
Broad Anti-inflammatory Approaches Feasible for Epilepsy: Nicholas Varvel, PhDThe assistant professor in the department of pharmacology and chemical biology at Emory University School of Medicine spoke about immune cells in epilepsy based on his special lecture at the 2022 AES Annual Meeting. [WATCH TIME: 4 minutes]
Latest:
Clinician and Patient Collaboration Advances Research and Epilepsy Care: Colin Josephson, MD, MSc, FRCPCThe associate professor of neurology at the University of Calgary spoke about advancing epilepsy care through patient-oriented research at the 2022 AES Annual Meeting. [WATCH TIME: 6 minutes]
Latest:
The Label of ‘Caregiver’Rebecca Whitney, associate director of Programs and Community Support at SRNA and mother of child with a rare neuroimmune disorder, provided thoughts on the importance of caregivers and the role they play in everyday life.
Latest:
AUPN Leadership Minute Episode 25: Patching the Holes in the Pipeline: Strategies to Enhance Diversity, Equity and Inclusion in NeurologyEpisode 25 of the AUPN Leadership Minute features Tracey A. Milligan, MD, of New York Medical College; and Mill Etienne, MD, of New York Medical College. [WATCH TIME: 8 minutes]
Latest:
Revolutionizing Treatment For Duchenne Muscular Dystrophy with Gene Editing: Courtney Young, PhDThe co-founder and chief executive officer of MyoGene Bio talked about the advantages of gene editing over traditional gene therapy as a long term treatment for neuromuscular diseases at MDA’s 2023 conference. [WATCH TIME: 3 minutes]
Latest:
The Implementation of Platform Trials for ALS Research: Melanie Quintana, PhDThe senior statistical scientist and director of consulting at Berry Consultants talked about innovative clinical trial design in ALS research at the 2023 MDA conference. [WATCH TIME: 5 minutes]
Latest:
Aparna V.R. Polavarapu, MD: Early Treatment for Infantile SpasmsThe pediatric neurologist at Montefiore Health System explains the importance of treating infantile spasms as early as possible and how it may impact outcomes.
Latest:
Key Takeaways From ANNEXA-I StudyDr Connolly highlights the cautious patient selection and the significance of reducing hematoma expansion for improved outcomes in cases of intracerebral hemorrhage (ICH) associated with the use of a reversal agent for factor Xa inhibitors.
Latest:
Mission Behind Cure CMD’s Research Roundtable, Efforts Around CMDs: Rachel AlvarezThe executive director of Cure CMD discussed efforts being done to bring the stakeholder community together and improve the care for patients with congenital muscular dystrophies. [WATCH TIME: 4 minutes]
Latest:
Concluding Thoughts on Biosimilars in Multiple SclerosisAmy Perrin Ross, APN, Patricia Melville, NP-C, Aliza Ben-Zacharia, PhD, DNP, ANP-BC, and John Kramer, PA-C share their advice for facilitating uptake of biosimilars in clinical practices.
Latest:
Steven Arnold, MD: Assessing AMX0035 Efficacy in Alzheimer DiseaseThe managing director of the Interdisciplinary Brain Center at Massachusetts General Hospital discussed the process of determining the best situations for use of AMX0035.
Latest:
Exploring Gaps in RLS Treatment Through New 2024 Guidelines: Andy Berkowski, MD, PhDThe vice chair of the American Academy of Sleep Medicine’s Clinical Practice Guidelines Task Force commented on some of the unanswered questions following the recently published guidelines for restless legs syndrome. [WATCH TIME: 3 minutes]
Latest:
Role of Alpha-Synuclein in Accurate and Early Diagnosis of Parkinson Disease: Sameea Husain-Wilson, DOThe neurologist and director of movement disorder neurology at the Marcus Neuroscience Institute discussed how the Syn-One test utilizes alpha-synuclein and what this biomarker adds to the diagnosis of Parkinson disease. [WATCH TIME: 3 minutes]
Latest:
AUPN 2022 Veterans Health Administration WorkshopGlenn Graham, MD, PhD; and Sharyl Martini, MD, PhD, moderate a discussion with 4 clincial experts to advance specialized clinical care, education and research for Veterans with movement disorders, multiple sclerosis, epilepsy and seizures, and headache. [WATCH TIME: 1 hour, 52 minutes]
Latest:
Expanding KP1077’s Clinical Program to Address Narcolepsy and Other Conditions: Christal MickleThe cofounder and chief product development officer of Zevra Therapeutics talked about the phase 1 clinical trial of KP1077 for narcolepsy and potentially using it to treat other conditions. [WATCH TIME: 5 minutes]
Latest:
Differences in Approaches to Pediatric and Adult Sleep Disorders: Jodi A. Mindell, PhDThe associate director of the Sleep Center at Children’s Hospital of Philadelphia detailed the similarities and differences in how sleep disorders are viewed between children and adults. [WATCH TIME: 4 minutes]
Latest:
Neurologic Impacts of Long COVID, an Autoimmune Syndrome: Igor Koralnik, MDThe chief of neuroinfectious diseases and global neurology at Northwestern Medicine talked about a relatively new autoimmune condition, marked by mitochondrial dysfunction. [WATCH TIME: 2 minutes]
Latest:
Lessons Learned From Aducanumab Experience and Antiamyloid Therapies: Ian KremerThe executive director of the Lead (Leaders Engaged on Alzheimer’s Disease) Coalition provided thoughts on the journey and lessons learned from aducanumab (Aduhelm) following Biogen’s decision to remove it from market. [WATCH TIME: 8 minutes]
Latest:
Improving Alzheimer Diagnosis With Innovative Blood-Based Biomarker Tests and BD-Tau: Mike Miller, PhDThe chief operating officer at Quanterix Corporation talked about pioneering ultra-sensitive blood biomarkers for Alzheimer clinical diagnosis, aiming to enhance detection of brain-derived tau and amyloid status with innovative assays. [WATCH TIME: 4 minutes]
Latest:
CMSC Live: 2024 Annual Meeting Day 2Host Jeffrey Wilken, PhD, chats with Fred Lublin, MD; Brian Hutchinson, PT, MSCS; and Robert Motl, PhD, about the second day of the 2024 CMSC Annual Meeting in Nashville, Tennessee.
Latest:
Consistent Real-World Efficacy of Ofatumumab Therapy for Multiple Sclerosis: Jason Freeman, MD, MBAThe medial director of Novartis talked about findings from a real-world study assessing ofatumumab treatment for multiple sclerosis presented at the 2024 ACTRIMS Forum. [WATCH TIME: 3 minutes]
Latest:
Standardizing Clinical Practice for End of Life Care in Neuromuscular Diseases: Lauren Treat, MDThe child neurologist at the University of Colorado School of Medicine talked about her presentation on end of life care for patients with neuromuscular diseases at the 2023 MDA conference. [WATCH TIME: 5 minutes]
Latest:
Future Directions for the Management of MigraineBradley Torphy, MD, and Julio R. Vieira, MD, share unmet needs and clinical pearls for the management of migraine.
Latest:
Unveiling the Role of Estrogen in Women's Cognitive Health: Lisa Mosconi, PhDThe director of the Weill Cornell Women’s Brain Initiative discussed emerging research that highlight the significant impact of sex hormones on women's brain health, and how it influences conditions like Alzheimer disease. [WATCH TIME: 8 minutes]
Latest:
Advice for Physicians and the Multiple Sclerosis CommunityThe panel shares final advice for the multiple sclerosis community.
Latest:
Intervening Early in MS With Exercise: Ulrik Dalgas, PhDThe professor of public health and sports science at Aarhus University shared his perspective on the potential to modify multiple sclerosis disease progression with lifestyle interventions. [WATCH TIME: 2 minutes]
